R
Roland Stocker
Researcher at Victor Chang Cardiac Research Institute
Publications - 341
Citations - 36707
Roland Stocker is an academic researcher from Victor Chang Cardiac Research Institute. The author has contributed to research in topics: Antioxidant & Lipid peroxidation. The author has an hindex of 92, co-authored 331 publications receiving 34364 citations. Previous affiliations of Roland Stocker include Australian National University & Chugai Pharmaceutical Co..
Papers
More filters
Journal ArticleDOI
Bilirubin is an antioxidant of possible physiological importance
TL;DR: The data support the idea of a "beneficial" role for bilirubin as a physiological, chain-breaking antioxidant.
Journal ArticleDOI
Role of Oxidative Modifications in Atherosclerosis
Roland Stocker,John F. Keaney +1 more
TL;DR: An "oxidative response to inflammation" model is proposed as a means of reconciling the response-to-injury and oxidative modification hypotheses of atherosclerosis.
Journal ArticleDOI
Biochemistry and pathology of radical-mediated protein oxidation
TL;DR: Proteins are also key targets in defensive cytolysis and in inflammatory self-damage, and the possibility of selective protection against protein oxidation (antioxidation) is raised.
Journal ArticleDOI
Antioxidant defenses and lipid peroxidation in human blood plasma.
TL;DR: The data suggest that in states of leukocyte activation and other types of acute or chronic oxidative stress such a simple regimen as controlled ascorbate supplementation could prove helpful in preventing formation of lipid hydroperoxides, some of which cannot be detoxified by endogenous plasma activities and thus might cause damage to critical targets.
Journal ArticleDOI
Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol
TL;DR: Investigation of the temporal disappearance of natural antioxidants associated with human low density lipoprotein (LDL) in relation to the appearance of various classes of lipid hydroperoxides shows that ubiquinol-10 is much more efficient in inhibiting LDL oxidation than either lycopene, beta-carotene, or alpha-tocopherol.